According to a research report published by Spherical Insights & Consulting, the Global Graves’ Disease (Overactive Thyroid) Market Size is Expected to Grow from USD 390.8 Million in 2023 to USD 614.6 Million by 2033, at a CAGR of 4.63% during the forecast period 2023-2033.

Get a Sample PDF Brochure:  https://www.sphericalinsights.com/request-sample/4753

Graves’ disease, also called Basedow’s disease, is an autoimmune hyperthyroid disorder. In this condition, the thyroid gland organ receives undue attention from the immune system, and subsequently, too many thyroid hormones get secreted into the body. Graves’ disease treatment aims to prevent the body from synthesizing thyroid hormones and also stop these hormones from exercising their actions. Propranolol and metoprolol are the first types of beta-blockers, recommended for use in treatment therapy. One of the most common reasons for hyperthyroid secretions in the blood causing hyperthyroidism is Graves’ disease autoimmune approach. Antithyroid medications block the production of thyroid hormones by the thyroid gland. Furthermore, increased the global prevalence of the condition known as overactive thyroid or Graves’ disease, thereby enhancing further the growth of the market. Hyperthyroidism has several adverse effects including heart problems such as increased heart rate, atrial fibrillation abnormality of the heart rhythm that raises stroke risk, and congestive heart failure the heart is unable to pump enough blood to meet the requirements of the organs. However, the exorbitantly priced cost of treatment will further hinder the rate of growth of markets.

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Graves’ Disease (Overactive Thyroid) Market Size, Share, and COVID-19 Impact Analysis, By Treatment (Anti-Thyroid Drugs, Beta Blockers, Iodine Therapy, Radioactive Iodine Therapy, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Buy Now Full Report:https://www.sphericalinsights.com/checkout/4753

The anti-thyroid drugs segment is expected to hold the greatest market share through the forecast period.

On the basis of treatment, the global Graves’ disease (overactive thyroid) market is divided into anti-thyroid drugs, beta-blockers, iodine therapy, radioactive iodine therapy, and others. Among these, the anti-thyroid drugs segment is expected to hold the greatest market share through the forecast period. This is attributed to the anti-thyroid drugs are easy to take and don’t need hospital stays, they are classically the initial line of therapy for Graves’ disease.

The oral segment is expected to grow at a rapid CAGR growth through the forecast period.

On the basis of the route of administration, the global Graves’ disease (overactive thyroid) market is divided into oral, parenteral, and others. Among these, the oral segment is expected to grow at a rapid CAGR growth through the forecast period. This is attributed to the oral route is a painless, non-invasive method that mainly consists of antithyroid pills and also provides self-administration of medication.

The hospital pharmacies segment is expected to hold the greatest revenue share through the forecast period.

On the basis of the distribution channel, the global Graves’ disease (overactive thyroid) market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the hospital pharmacies segment is expected to hold the greatest revenue share through the forecast period. This is attributed to the hospital pharmacy providing healthcare facilities, and patients can obtain prescription drugs directly from on-site pharmacies.

Inquire Before Buying This Research Report:https://www.sphericalinsights.com/inquiry-before-buying/4753

North America is expected to hold the greatest share of the global Graves’ disease (overactive thyroid) market over the projected timeframe.

North America is expected to hold the greatest share of the global Graves’ disease (overactive thyroid) market over the projected timeframe. Most of the pharmaceutical companies’ research and develop drugs for Graves’ disease in North America. The medications for Graves’ disease are mostly in demand due to the increase in thyroid diseases and health costs in the United States and Canada. There is a strong regulatory framework, and it has a good reimbursement environment that clears innovative products.

Asia Pacific is anticipated to grow at a rapid CAGR growth of the global Graves’ disease (overactive thyroid) market during the forecast period. The growing awareness of healthcare and the availability of access to healthcare services will open opportunities for market participants in developing countries such as China and India. These two have a sizeable patient population suffering from thyroid diseases due to changing lifestyles and genetic tendencies. Asian patients can afford Graves’ disease treatments with the increased availability of local generic meds.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the global Graves’ disease (overactive thyroid) market are Allergan, AstraZeneca, Sling Therapeutics, Inc, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Merck KGaA, Novartis AG, Mindray, HanAll Biopharma Co., Ltd., Mylan N.V., Aspen Pharmacare Holdings Ltd, GlaxoSmithKline plc, Horizon Therapeutics plc, Alara Pharmaceutical Corporation, and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development

• In June 2022, Sling Therapeutics, Inc. is a biopharmaceutical company led by TPG’s The Rise Fund, which has just announced the raising of a USD 35 million Series. These funds will help facilitate a Phase 2b clinical trial evaluating the company’s investigational medicine, sunitinib, as a treatment for thyroid eye disease (TED). TED primarily afflicts women and most frequently courses along with hyperthyroidism because of Graves’ disease.

• In May 2022, Mindray introduced an assay for TRAb that is used in the diagnosis and management of Graves’ disease. Thyrotropin receptor antibody (TRAb), known as the pathogenic antibody in Graves’ disease, aids as a pivotal serum biomarker aiding in diagnosis.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global Graves’ disease (overactive thyroid) market based on the below-mentioned segments:

Global Graves’ Disease (Overactive Thyroid) Market, By Treatment

• Anti-thyroid Drugs
• Beta Blockers
• Iodine Therapy
• Radioactive Iodine Therapy
• Others

Global Graves’ Disease (Overactive Thyroid) Market, By Route Of Administration

• Oral
• Parenteral
• Others

Global Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Graves’ Disease (Overactive Thyroid) Market, By Regional Analysis

• North America

• • US
  • Canada
  • Mexico

• Europe

• • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

• Asia Pacific

• • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

• South America

• • Brazil
  • Argentina
  • Rest of South America

• Middle East & Africa

• • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

Bowse Related Reports:

Global Fixed Human Anesthesia Workstation Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Standard Anesthesia Workstations, High-End Anesthesia Workstations, and Portable Anesthesia Workstations), By Application (General Surgery, Pediatric Surgery, Cardiac Surgery, Orthopedic Surgery, and Emergency Procedures), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.

Global Cardioverter Defibrillator Device Market Size, Share, and COVID-19 Impact Analysis, By Type (Implantable Cardioverter Defibrillators, and External Cardioverter Defibrillators), By End User (Hospitals, Pre-Hospital, Public Access Market, Alternative Care, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.

Global Medical Syringe Drive Systems Market Size, Share, and COVID-19 Impact By Product Type (Electronic Syringe Drive Systems and Mechanical Syringe Drive Systems), By Application (Hospitals, Ambulatory Surgical Centers, Clinics, Home Care Settings, and Others), By End-User (Healthcare Providers, Patients, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Global Anesthesia Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Anesthesia Delivery Machine, Anesthesia Disposables & Accessories, Anesthesia Monitors, and Anesthesia Information Management Systems (AIMS)), By End User (Clinics, Ambulatory Service Centers, and Hospitals), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements.

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter